基本信息
views: 446

Bio
Skills
Pharmacokinetics
Drug Delivery
Drug Discovery
Pharmacology
In Vivo
Drug Development
Biotechnology
Clinical Trials
Clinical Development
In Vitro
Pharmacodynamics
Biochemistry
Pharmacokinetics
Drug Delivery
Drug Discovery
Pharmacology
In Vivo
Drug Development
Biotechnology
Clinical Trials
Clinical Development
In Vitro
Pharmacodynamics
Biochemistry
Research Interests
Papers共 610 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Lu Wang,Rebecca Voss,Victor Pastor,Maria Cardenas,Priyadarshini Kumar,Jamie Maciaszek, Maria Namwanje,Jing Ma, Jennifer Neary, Meiling Jin,Masayuki Umeda, Mark Wilkinson,Debbie Payne-Turner, Mohammad Eldomery,Jingqun Ma,Jiali Gu,James Dalton, Samantha Melton,Yen-Chun Liu,Scott Foy,Michael Rusch,David Wheeler, Jinghui Zhang,Kim Nichols,Seth Karol,Hiroto Inaba,Raul Ribeiro,Jeffrey Rubnitz,Jeffery Klco
Research square (2025)
Marc Zuckermann,Chen He,Jared Andrews,Aditi Bagchi, Roketa Sloan-Henry,Brandon Bianski,Jia Xie,Yingzhe Wang,Nathaniel Twarog,Arzu Onar-Thomas,Kati J. Ernst,Lei Yang,Yong Li,Xiaoyan Zhu, Jennifer K. Ocasio, Kaitlin M. Budd,James Dalton,Xiaoyu Li,Divyabharathi Chepyala, Junyuan Zhang,Ke Xu,Laura Hover,Jordan T. Roach,Kenneth Chun-Ho Chan,Nina Hofmann,Peter J. McKinnon,Stefan M. Pfister,Anang A. Shelat,Zoran Rankovic,Burgess B. Freeman,Jason Chiang,David T. W. Jones,Christopher L. Tinkle,Suzanne J. Baker
MOLECULAR CANCERno. 1 (2024)
crossref(2023)
openalex(2023)
openalex(2023)
openalex(2023)
openalex(2023)
openalex(2023)
openalex(2023)
openalex(2023)
Load More
Author Statistics
#Papers: 610
#Citation: 33798
H-Index: 84
G-Index: 163
Sociability: 8
Diversity: 3
Activity: 14
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn